share_log

济川药业:子公司两产品首次纳入国家医保目录

hubei jumpcan pharmaceutical: Two products of its subsidiary are included in the national medical insurance catalog for the first time.

Breakings ·  Dec 1 01:35

Hubei Jumpcan Pharmaceutical announced that its wholly-owned subsidiary, Hubei Jumpcan Pharmaceutical Group Co., Ltd., has successfully negotiated to include its products, Pediatric Chiqiao Qingre Syrup and Fexofenadine Hydrochloride Dry Suspension, for the first time in the National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Pharmaceutical Catalog (2024).

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment